Bixiang Zhang

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Zhenggang Ren, Jianming Xu, Yuxian Bai et al. · The Lancet Oncology · 2021 · 1K citations

Hepatology, Bevacizumab Biosimilar, Medicine +8

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2020 · 813 citations · Full text

ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection

Furong Liu, Xin Long, Bixiang Zhang et al. · Clinical Gastroenterology and Hepatology · 2020 · 673 citations · Full text

Research on Geographical Environment Unit Division Based on the Method of Natural Breaks (Jenks)

Jian Chen, Saini Yang, H. W. Li et al. · ˜The œinternational archives of the photogrammetry, remote sensing and spatial information sciences/International archives of the photogrammetry, remote sensing and spatial information sciences · 2013 · 438 citations · Full text

Engineering, Land Use, Environmental Impact Assessment +16

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2023 · 389 citations · Full text